www.fdanews.com/articles/120160-roche-europe-approves-drug-for-advanced-leukaemia
Roche: Europe Approves Drug for Advanced Leukaemia
September 3, 2009
The European Commission has approved Roche Holding AG’s MabThera cancer drug to treat patients whose chronic lymphocytic leukaemia returns, the Swiss drugmaker said.
Forbes
Forbes